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Many nonpharmaceutical chemical contami-
nants, particularly those that are lipophilic
and of relatively low molecular weight, can
accumulate in breast milk. The potential
health effects of these contaminants, also
known as xenobiotics, on both mother and
child is of great concern, making it important
to carefully monitor contaminant levels and
trends. Although some countries, most
notably Sweden and Germany, have ongoing
breast milk monitoring programs in place,
data from the rest of the world are spotty.
Few data exist for the United States and for
most developing countries, particularly over
the past two decades. Many of the studies
that have been conducted are small and not
necessarily representative of the larger popu-
lation of the country where sampling was
done. Almost all of the studies on xenobiotics
in breast milk have focused on the same
chemicals: organochlorine pesticides, poly-
chlorinated biphenyls (PCBs), and dioxins.
Few data are available on metals, solvents,
and other chemicals. The fact that most stud-
ies have focused on the same panel of persis-
tent organic pollutants (POPs) is problematic
because it limits the ability to detect new or
rising trends in contaminants and thereby
may impede effective public health responses.
Efforts to compare levels of speciﬁc envi-
ronmental contaminants across time and
place are limited by other obstacles. There
has historically been no standardized method
for conducting breast milk monitoring 
studies, with the partial exception of those
studies coordinated by the World Health
Organization (WHO) (1). A range of issues
including donor selection, the timing of
sample collection, the use of preservatives in
archived samples, and different methods for
estimating population averages (pooled vs.
single sample detection) can all signiﬁcantly
affect the results of a study and have made
comparisons difﬁcult (2,3). Studies may also
differ in their data reporting or in their mea-
surement variables. This is problematic
because the quantity and presence of differ-
ent congeners, metabolites, and impurities
reflect different exposure scenarios and dif-
ferent stages in metabolism. Some studies
report levels only for a subset of chemicals,
so it is difficult to determine if gaps are a
result of analytic limitations or if the data
truly reﬂect different types of exposure. 
The data that do exist suggest that bans
and restrictions in recent decades on the use
of many of the POPs have led to a decline in
levels of these chemicals in breast milk (3–6).
Conversely, there are other chemicals that
have only recently been tested in breast milk
whose levels may be increasing. The poly-
brominated diphenyl ethers (PBDEs), cur-
rently used as ﬂame retardants, are the only
set of chemicals known to be on the rise in
breast milk (7); nothing can be said about the
many chemicals not included in test panels.
All investigations of contaminants in
breast milk must be sensitive to the overriding
beneﬁts of breast-feeding. The advantages of
breast-feeding have been documented in the
neonatal period and extend throughout
childhood and into adulthood (8). There are
also clear health beneﬁts to the mother (9).
Breast-feeding confers nutritional, immuno-
logic, neurologic, and emotional advantages
that have been well documented (10).
Although the weight of the scientific evi-
dence to date indicates that the advantages
of breast-feeding outweigh any risks from
contaminants in breast milk, it is important
to identify contaminant trends, locate dis-
proportionately exposed populations, and
take public health measures to decrease and
eliminate xenobiotics from breast milk. A
review of data on levels of contaminants in
breast milk from women around the world
can provide useful information for guiding
exposure reduction efforts and for demon-
strating the utility of more consistent, rou-
tine, breast milk monitoring for a broader
spectrum of chemical contaminants. 
Study Design and Data
Comparability
Numerous methodologic discrepancies in
study design, sample analysis, and reporting
make interpretation of the literature on con-
taminants in breast milk challenging. 
Many of the studies are limited by small
sample sizes. This problem is compounded
by the common practice of pooling samples
from study populations so that only an aver-
age is available, and variability within the
group is not examined. Many studies include
data from women of various ages, parity, and
duration of breast-feeding. Because levels of
many contaminants are associated with age,
parity, and duration of lactation, the mixing
of breast milk samples from women with
these various characteristics makes it more
difficult to identify differences related to
actual exposure conditions. The selection of
study participants may also bias study
results. Some studies may have selected
women participants based on potentially
high exposure to the chemical of interest so
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Research on environmentally related chemical contaminants in breast milk spans several decades
and dozens of countries. The ability to use this research as an environmental indicator is limited
because of a lack of consistent protocols. Data on xenobiotics in breast milk are influenced by
choices in sample selection, sample pooling, analysis, and reporting. In addition, most studies have
focused only on a small panel of persistent organic pollutants, despite indications that a wide range
of additional chemical contaminants may also enter breast milk. Despite these limitations, how-
ever, it is possible to draw some generalizations. In this paper we review available data on levels of
organochlorine pesticides, polychlorinated biphenyls (PCBs), polychlorinated dibenzodioxins
(PCDDs), polybrominated diphenyl ethers (PBDEs), metals, and solvents in breast milk. Examples
drawn from around the world illustrate the available data and the patterns that have appeared in
various areas over time. Over the past few decades, levels of the organochlorine pesticides, PCBs,
and dioxins have declined in breast milk in countries where these chemicals have been banned or
otherwise regulated. In contrast, the levels of PBDEs are rising. Regional differences in levels of
xenobiotics in breast milk are related to historical and current local use patterns. Diet is a major
factor that inﬂuences breast milk levels of persistent organic pollutants, with patterns in ﬁsh con-
sumption playing a particularly signiﬁcant role. Improved global breast milk monitoring programs
would allow for more consistent data on trends over time, detection of new xenobiotics in breast
milk, and identification of disproportionately exposed populations. Key words: breast-feeding,
breast milk, chemical contaminants, dioxins, pesticides, pollutants, polychlorinated biphenyls.
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Perhaps the most critical methodologic
challenge relates to chemical analysis. Analytic
methods have varied widely. For example, it is
difﬁcult to compare studies of PCBs in breast
milk because of differences in the number of
PCB congeners measured, differences in the
analytic method used, and differences in
reporting the results (11). This issue can also
be seen with the choice of dioxin congeners
measured. In studies of dioxin levels in breast
milk, the congener 2,3,7,8-tetrachloro-
dibenzo-p-dioxin (TCDD) is almost always
measured. However, different researchers may
measure different assortments of the remain-
ing dioxins and furans. For coordinated stud-
ies, all 17 congeners must be measured so that
data are comparable (1,12). Measurement
issues are also evident with organochlorine
pesticides that may have different metabolites
measured in different studies. For example,
numerous forms of the pesticide chlordane
can be found in breast milk (oxychlordane,
trans-nonachlor, cis-nonachlor, etc.). The
quantity and presence of these different
metabolites and impurities reflect different
exposure scenarios and stages in metabolism.
Depending on the study, there may only be
levels reported for certain forms of the chemi-
cal. It is difﬁcult to determine if these gaps are
a result of analytic limitations or if the data
truly reﬂect different types of exposure. 
There are also distinct differences in the
way breast milk monitoring data are reported.
Some studies do not present information on
the base population sampled, including occu-
pational exposures, ages, parity, and other rel-
evant variables. Furthermore, the conventions
for reporting results have changed over time.
For example, unlike many other chemicals
whose toxicity is expressed in terms of a mea-
sured concentration, toxicity of dioxins and
furans is conventionally expressed in terms of
toxic equivalencies (TEQs) (13). The most
common is WHO’s International TEQ, or
I-TEQ (13). But some studies use other toxic
equivalency calculation schemes. In such
cases, it is difficult to compare these with
studies using I-TEQs.
Most methodologic problems stem from
the lack of a standardized protocol for con-
ducting breast milk monitoring programs.
Many scientists have called for the adoption
of a consistent method based on the WHO
protocol, which addresses some (but not all)
of the challenges described above (3,12,14).
Review of Available Data by
Chemical
Despite the difﬁculties in generalizing across
studies, there are some consistent predictors
of levels of contaminants in breast milk (4).
Levels of POPs are inﬂuenced by global and
local use patterns of the chemical and by
diet, maternal age, parity, and duration of
lactation (15). Heavier local or regional use
of POPs is consistently associated with ele-
vated local or regional levels of residues in
breast milk samples (16,17). However, the
absence of local use does not mean that no
contamination is detectable. Long-range
transport and diet has resulted in detectable
breast milk residues in countries where these
chemicals were never used (18). 
It is perilous to extrapolate from observed
levels of contaminants in breast milk around
the world to predict potential health effects
or to declare specific levels safe. Although
some regulatory agencies have set benchmark
levels for some contaminants in breast milk,
these benchmarks may not be completely
reliable. Different international and national
agencies may set different benchmark levels.
In addition, some scientists have questioned
whether current benchmark levels adequately
protect the developing neonate from some of
the more newly recognized health effects of
organochlorine contaminants, such as
endocrine-disrupting effects (4). In general,
however, the levels of the organochlorine pes-
ticides in countries where these chemicals
have been banned have dropped well below
all current benchmark levels. Commonly
detected levels of dioxins and polychlorinated
biphenyls, on the other hand, are above most
regulatory benchmarks (19). 
In the absence of poisoning incidents or
local exposure, dietary exposure has been
shown to be an important predictor of levels
of many POPs in breast milk. In Germany,
Schade and Heinzow (20) showed that
women who ate a healthy diet (low meat
consumption and high vegetable and fruit
intake) for at least 3 years had much lower
levels of hexachlorobenzene (HCB) and
hexachlorohexane (HCH) in their breast
milk compared to women who ate more
than 700 g of meat per week. Dioxin expo-
sure has also been shown to be strongly cor-
related with diet (21). Vegetarian mothers
have been shown to have lower levels of
dioxin in their milk compared to women
who eat a diet rich in meat (22). 
In general, bans on the production or use
of POPs have been associated with decreasing
residues of these chemicals in breast milk
samples over the subsequent decades (5).
Although levels have not declined to zero,
there is evidence of downward trends.
Conversely, continued use of POPs is associ-
ated with time-related increases in breast milk
contamination. The following sections review
some of the data on speciﬁc chemicals to illus-
trate time trends and regional differences in
breast milk levels of common contaminants.
Chlordane. Chlordane, a mixture of more
than 26 compounds, is an organochlorine
cyclodiene pesticide. Chlordane has been
used as an agricultural pesticide, on home
lawns and gardens, and against termites.
Chlordane has been banned in at least 47
countries and severely restricted in an addi-
tional 14 (23). Like most POPs, the break-
down of chlordane once it has attached to
soil particles or sediment is very slow; in
some cases, it has been found in soil up to 20
years after initial treatment (24). Chlordane
is rapidly metabolized in organisms into oxy-
chlordane and γ-chlordane or into impurities
such as trans-nonachlor or cis-nonachlor. It is
these breakdown products that persist in the
tissue of ﬁsh, birds, and mammals and that
are found in breast milk (25). 
Studies examining chlordane metabolites
in breast milk have been conducted in at least
14 countries, including Australia, Canada,
Israel, Japan, Kazakhstan, Mexico, Russia,
Spain, Thailand, the United States, and
Scandinavian countries (18,24–28). Data
from areas where chlordane was used show
signiﬁcant variability of levels associated with
use patterns. For example, in the 1970s in
the United States, lactating women in the
southern states had an average of 113 ng/g
lipid (range 108–118 ng/g) of chlordane in
their milk compared to 79 ng/g (range
76–82 ng/g) among women living in other
regions, probably due to agricultural use and
more intensive home termite control (24).
Similarly, in Japan in the 1980s, women liv-
ing in homes where chlordane was used for
termite control had breast milk chlordane
levels 4.4 times higher than women whose
households used no form of chlordane (27).
Chlordane residues, however, have not
been conﬁned to regions where the chemical
was used. For example, chlordane was
detected in the breast milk of women in
Finland in the mid-1980s, even though the
chemical was never used in Finland and was
heavily restricted in neighboring countries.
Exposure has been attributed to bioaccumu-
lation in Baltic ﬁsh (18).
Despite the persistence of chlordane in
the environment, data from Sweden demon-
strate a declining trend in average breast
milk residues of chlordane metabolites in the
decades since the chemical was banned in
most European countries (28,29). The peak
concentrations of chlordane reported in the
1970s in Sweden were 4- to 5-fold lower
than the contemporaneous average concen-
trations found in the United States (25).
Dieldrin and aldrin. Dieldrin and aldrin
are closely related organochlorine insecti-
cides that are extremely persistent in the
environment. Both pesticides have been used
in agriculture, and dieldrin was also used for
vector control, for veterinary purposes, and
for termite control (30). In both plants and
animals, aldrin quickly converts to dieldrin.
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down very slowly, does not easily evaporate
into the air, and binds to soil particles.
Plants take up aldrin and dieldrin residues
directly from the soil. In animals, including
humans, dieldrin is stored in the fat and
leaves the body very slowly (31). Dieldrin
and aldrin are the most widely banned and
restricted class of pesticides in the world
(32). As of 1995, aldrin and dieldrin had
been banned or severely restricted in more
than 70 countries (23). 
Studies evaluating residues of aldrin and
dieldrin in breast milk have been conducted in
at least 28 countries, including Brazil, France,
Great Britain, Greece, Italy, Kenya, Saudi
Arabia, Ukraine, and Vietnam. Dieldrin has
been found in > 99% of breast milk samples
tested in most countries (33). Because dield-
rin is lipophilic and breast milk contains a
much greater lipid concentration than blood,
the level of dieldrin in a woman’s milk is gen-
erally about six times higher than the level in
her blood. 
When dieldrin and aldrin ﬁrst came into
widespread international use, detection preva-
lence in breast milk rose dramatically. As
countries have restricted and banned the use
of both chemicals, the prevalence of detection
has remained high, but levels detected in
breast milk have dropped significantly
(25,28,34). Some countries have seen a 10-
fold decrease in the level of detectable dieldrin
in the years following restrictions. Data from
Sweden show a clear decrease in average levels
of dieldrin detected in breast milk over several
decades (Figure 1) (28). Data from Canada,
Denmark, Germany, and Japan also show
apparent decreases over time (25,35,36).
Insufficient studies have been conducted in
the United States, making it impossible to
reliably document changes in dieldrin residues
over time. The few data available suggest that
the ban in the United States may have
resulted in similar decreases (25,35). 
In some countries with ongoing dieldrin
use, breast-milk levels relate closely to local
use patterns (16,37). In areas where dieldrin is
used more heavily, levels in breast milk are
often significantly higher. Studies in
European countries and in the United States
when dieldrin was still in use showed signiﬁ-
cantly higher concentrations of dieldrin in
breast milk in southern areas than in northern
areas. This has been attributed to higher
agricultural pesticide use in the southern
areas (25). Kenya still uses dieldrin in agri-
culture, and breast milk of women living in
areas with intensive agricultural production
has much higher levels of dieldrin than
breast milk from women in nonagricultural
areas. Figure 2 shows the differences in aver-
age dieldrin levels in breast milk during the
1980s around Kenya; the agricultural areas
of Loitokitok had the highest levels (16,17).
The dieldrin concentrations in Loitokitok
are extremely high compared to benchmarks.
For example, the U.S. Food and Drug
Administration established an action level
(the level at which it will consider removing
a product from the market) for dieldrin
residue in cow’s milk of 7.5 ng/g lipid (15).
The Kenyan study showed concentrations
more than 300 times this level in breast
milk. However, it is important to note that
this benchmark has not been established as a
true safety level for dieldrin. It differs from
other benchmarks established by Codex
Alimentarius and the WHO (33). There
have been no studies that we are aware of
evaluating exposures to dieldrin and adverse
health effects in breast-fed children.
DDT. DDT (dichlorodiphenyltrichloro-
ethane) is a commercial organochlorine
insecticide that has been widely used on agri-
cultural crops as well as for vector control
(38). DDT and its by-products can persist in
soil and sediments for more than 15 years
and are known to bioaccumulate in animal
tissues. As of 1995, DDT had been banned
for all uses in 49 countries and restricted to
vector control in 23 (23). 
The half-life of DDT in humans is
approximately 4 years. DDT’s major metabo-
lite, dichlorodiphenylchloroethane (DDE),
has a half-life of approximately 6 years (28).
The relative proportion of DDT and DDE
detected in human tissues can be an indica-
tion of the length of time since exposure. In
areas where DDT exposure is recent, the
DDE/DDT ratio is low, whereas in areas
where substantial time has passed since use,
the DDE/DDT value is higher. Because
DDE is attracted to fat, levels in breast milk
are often six to seven times higher in a
mother’s milk than in her blood (39).
Although DDT residues in breast milk
have been measured in more than 60
countries, only a few nations have compre-
hensive trend data where multiple studies
have been done over time, using large study
populations and consistent methods. After
the restriction and ban of DDT in some
nations, average breast-milk levels decreased
substantially. Smith (5) analyzed trend data
from around the world and found that the
average levels of DDT in breast milk in most
countries declined in direct correlation with
the length of time since DDT restriction.
DDT levels in breast milk in Sweden con-
tinuously declined from 1967 through 1997
(Figure 3) (28). The use of DDT was
severely restricted in Sweden in 1970 and
completely banned in 1975. Germany has
also witnessed a rapid decline in average con-
centrations of DDT in breast milk. Between
1969 and 1995, detectable residue levels
decreased by 81%. DDT was banned in
Germany in 1972 (20,22,25,36,40,41).
Other countries where studies have revealed
a downward trend include Canada,
Denmark, Norway, Switzerland, Turkey,
Yugoslavia, the Czech Republic, Great
Britain, Hong Kong, Israel, India, and Japan
(18,25,40,42,43).
The difference between areas that cur-
rently apply DDT and those that have only
the residue of past exposures is particularly
evident in data from Zimbabwe and Mexico.
DDT was banned for agricultural use in
Zimbabwe in 1982 (44), but national aver-
ages for DDT in breast milk still show mod-
erately high levels (~6,000 ng/g DDT in
lipid). Exposure is generally in the form of
DDE, indicating that exposure to DDT was
not recent. However, the Kariba region of
Zimbabwe, the only region that still actively
uses DDT for malaria control, shows much
higher levels of total DDT residues (> 25,000
ng/g DDT in lipid) (44). In 1984, WHO
established an acceptable daily intake (ADI)
level for consumption of DDT in milk. This
value of 20 µg/kg/day can be converted into
an acceptable level of 5,000–6,000 ng/g
DDT in lipid (5). The levels of DDT in some
regions of Zimbabwe are above that level.
In Mexico, DDT use has been partially
restricted since 1972 and more stringently
restricted since 1990. Since that time, overall
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Figure 1. Dieldrin in breast milk in Sweden. Figure 3. DDT in breast milk in Sweden.
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Figure 2. Dieldrin in breast milk in Kenya, 1983–1985.average DDT levels in breast milk appear to
have declined (45–48). Despite this down-
ward trend, regional data give cause for con-
cern in those parts of Mexico where DDT
continues to be used for malaria control. In
the suburban area near Veracruz City, for
example, DDT is sprayed at least every 6
months on indoor surfaces and dwellings.
Women from suburban areas of Veracruz have
higher levels of DDT in their breast milk
(average of 10,000 ng/g lipid) than do urban
or rural residents of the same area (2,600 and
8,000 ng/g lipid, respectively). In addition, the
ratio of DDE/DDT is lower in suburban
women, suggesting that these women’s residue
levels stem from recent, direct exposure. In
contrast, the women from the urban and
rural areas have high DDE/DDT ratios, sug-
gesting that their breast-milk levels have risen
from historical exposures or from exposures
through food (49).
The average levels of DDT in breast milk
have varied considerably among nations.
Figure 4 shows the wide range of levels of
DDT found in breast milk in different coun-
tries between 1974 and 1976. It was during
this time that many industrialized nations
banned or began to restrict the use of DDT.
At about the same time, use of DDT in
developing nations was peaking (18,25,28,
34,42,43,45,50–55). Figure 4 reflects data
from studies with different designs (as dis-
cussed previously). For some of the countries
included in the ﬁgure, multiple studies may
have been conducted in the same time
period. Where multiple studies were con-
ducted, the study with the largest study pop-
ulation was included in the ﬁgure (25,28,34).
Some of the studies were included because no
other data for that country exist. This graph
illustrates the wide variation that may exist
between regions worldwide. 
Heptachlor. Heptachlor is an organochlo-
rine cyclodiene pesticide that has been used to
control termites and as an insecticide on seed
grains and food crops. Heptachlor epoxide,
the main metabolite of heptachlor, is
extremely persistent in soil. In some cases,
trace amounts of heptachlor epoxide have
been found in soil 14–16 years after applica-
tion (56). Plants can draw heptachlor epoxide
directly from the soil, and the chemical bioac-
cumulates in animals. Heptachlor has been
banned or restricted in more than 60 coun-
tries (23,57). However, some of these coun-
tries still permit its use for termite and other
pest control, and many developing nations
still use heptachlor for agricultural purposes
(58). Despite the imposition of a ban on use
in the United States in 1988, U.S. customs
data showed that heptachlor was exported in
large quantities through 1994 (59).
Judging from available data, heptachlor
epoxide residue levels in breast milk appear
to be decreasing. However, in the time frame
for which data are available, the incidence of
contamination increased. Early studies often
detected heptachlor and heptachlor epoxide
in < 10% of samples tested, whereas later
studies approached 100% detection with
similar analytic methods. As countries have
restricted and banned heptachlor, levels
detected in breast milk have dropped, often
by more than 10-fold (25). 
In Alberta, Canada, between 1966 and
1978, the average levels of heptachlor epoxide
increased from an average of 2 ng/g lipid to 29
ng/g lipid (35). More striking, however, was
the increase in the incidence of detection.
From 1966 to 1970, only 5% of collected
samples contained detectable levels of hep-
tachlor epoxide. In a 1977–1978 study, the
detection incidence had increased to 94% of
collected samples (35). The use of heptachlor
in Canada was discontinued in 1985 (57).
The limited data available suggest that levels in
breast milk have probably begun to decrease.
Regional differences have also been
reported. In the United States, levels in the
Southeast were nearly double the levels in
the rest of the country during the period
when heptachlor was still used (24). When
heptachlor was still used in Belgium, women
in the north had breast milk levels 4-fold
higher than women in the south, probably
related to agricultural use patterns (25). In
Spain, a more than a 2-fold difference in
heptachlor epoxide levels was found between
rural and urban populations, probably due
to agricultural use in rural areas (25). 
Hexachlorobenzene. HCB is a persistent
organochlorine chemical that is both a pesti-
cide and an industrial by-product. Its main
use is as a fungicide on seed grains (25).
HCB is formed as an industrial by-product
in chlorination processes, such as wastewater
treatment (60). It also forms as a by-product
in the manufacturing and production of the
wood preservative pentachlorophenol, of
chlorinated solvents such as perchloroethyl-
ene and carbon tetrachloride, and of various
pesticides (25,60). HCB binds strongly to
soil particles as well as to sediment and builds
up in plants when it is present in soil (61).
Poisoning incidents in Europe and the
United States involving HCB have illustrated
the importance of diet as an exposure path-
way for breast milk contamination. In an
industrial area of Louisiana, cattle were quar-
antined because of high levels of HCB in
their milk and fat. The source of the contam-
ination was thought to be the area where the
cattle grazed, which had been contaminated
by the disposal of HCB wastes (60). The
most notorious example of breast milk conta-
mination by HCB occurred in Turkey in the
1950s. HCB-treated seed wheat intended for
agriculture was used for food. Between 1955
and 1959, about 500 people were fatally poi-
soned by eating bread made with the conta-
minated seed. More than 4,000 people
became ill as a result of the exposure. In some
villages, almost all breast-feeding children
under the age of 2 years whose mothers had
eaten tainted bread died. Locally, this condi-
tion was called pembe yara. In one mother’s
breast milk during the incident, the HCB
level was 20,000 ng/g in lipid, approximately
2,000 times the average levels of contamina-
tion found in breast milk samples around the
world (25,60). Follow-up studies 20–30
years after the poisoning found average HCB
levels in breast milk still more than 7 times
the average for unexposed women in that
part of the world (62,63) and 150 times the
level allowed in cow’s milk (64). 
Studies evaluating HCB in breast milk
have been conducted in at least 34 countries.
Historically, women in areas with less indus-
trialization have had signiﬁcantly lower levels
of HCB in their breast milk. For instance,
average HCB levels detected in breast milk in
Kenya in the mid-1980s were just 1% of aver-
age levels found in Sweden and Germany at a
similar time (17). HCB levels in breast milk
have declined in some industrialized coun-
tries over the past two decades, probably as a
result of changes in fungicide use and proce-
dural improvements in industry that have
led to a reduction in the generation of HCB
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Figure 4. DDT in breast milk around the world, 1974–1976. 
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Yugoslaviaby-products (25,28,36). In Czechoslovakia,
higher levels of HCB in breast milk were
found in industrial areas. These areas (Prague
and Kladno) were home to a variety of indus-
tries that emitted HCB (65). A study in 1992
found that HCB levels in the breast milk of
women living in the Kola Peninsula of Russia
were twice as high as in Norway and the
Netherlands (66). This area also has much
higher levels of industrial pollution than
other parts of Europe.
Sweden has witnessed a clear decline in
the levels of HCB detected in breast milk
(Figure 5). In 1980, Sweden stopped using
HCB as a fungicide. In addition, HCB
production as an industrial by-product
decreased with improvements in industrial
technologies (28). Norway experienced a
similar decrease, with levels of HCB in
breast milk dropping by 65% between the
mid-1970s and early 1990s (67). Studies
conducted in Germany, Belgium, Canada,
Denmark, the Netherlands, and Switzerland
suggest a decline in the HCB levels found in
breast milk, with a decline of more than
85% in Germany (25).
Hexachlorocyclohexane. HCH is an
insecticide made up of a mixture of eight iso-
mers. Different isomer forms have different
levels of persistence and bioaccumulate in
breast milk differently. The γ-isomer of
HCH, also known as lindane, is widely used
as an insecticide directly applied to the body
and scalp to treat head and body lice. The β-
isomer of HCH is the most persistent and
bioaccumulative form. The α- and γ-isomers
of HCH are converted into the β-isomer in
organisms. As a result of this conversion, as
much as 90% of HCH detected in human
tissues and breast milk is β-HCH (25).
HCH is banned or severely restricted in more
than 60 countries. Lindane is specifically
banned or restricted in 46 countries (23), but
its use is often permitted for special uses by
exemption. For instance, in the United
States, mixed HCH has been banned as an
insecticide, but lindane is still allowed as a
pharmaceutical for topical application against
head lice and scabies, and as a seed treatment.
Studies evaluating HCH contamination
of breast milk have been conducted in 41
countries (25). In general, countries that have
monitored breast milk for HCH residues
over time have witnessed a steady decrease.
Clear downward trends have been reported
in the North Rhine Westphalia region of
Germany and in Stockholm, Sweden,
between 1974 and 1984 (Figure 6) (28,36).
Since Japan banned HCH in the 1970s, lev-
els of the pesticide in breast milk have
decreased (Figure 7) (25,55).
HCH levels in breast milk are extremely
variable and often reflect differences in
regional use and exposure patterns. Unusually
high levels of HCH in breast milk have been
associated with areas of high use. In China
and Japan, HCH was commonly used as an
insecticide in rice ﬁelds, and levels as high as
6,500 ng/g of HCH in lipid have been mea-
sured in these countries (25). A 1982 study
in Norway, a decade after HCH was banned
in that country, found higher levels of the
β-isomer of HCH in women who had
immigrated from developing countries.
Immigrant women had an average level of
433 ng/g β-HCH in their lipid, whereas
native Norwegian women had an average of
80 ng/g. The difference was attributed to the
likelihood of higher exposures in developing
countries (68).
Dioxins and furans. Dioxins and furans
are two closely related groups of chemical
by-products that are produced throughout
the world. The dioxin and furan congeners
thought to be most toxic to humans are the
7 dioxins and 10 furans known as the
2,3,7,8-congeners. Most studies measuring
human exposure to dioxins and furans focus
on this group. In breast milk monitoring
studies, the term “dioxin” refers to this
group of 17 congeners. 
Dioxins and furans are listed by several
governmental and international agencies as
known causes of cancer in humans. Studies
have also linked dioxins and furans to repro-
ductive problems, abnormalities in fetal
development, immune alterations, and dis-
ruption of hormones (19). Unlike other con-
taminants discussed in this paper where little
research into the health effects of low-level
exposure is available, there has been consid-
erable work showing effects of dioxin expo-
sure at low levels near the range detected in
breast milk (13). Dietary exposure makes up
more than 90% of human dioxin intake
(21). Because dioxins and furans are so
persistent, lactation is one of the main routes
of excretion.
Dioxins and furans have been measured
in the breast milk of women from at least 35
countries, including Albania, Cambodia,
Croatia, Estonia, the Faeroe Islands, India,
Jordan, New Zealand, Pakistan, South Africa,
Thailand, Vietnam, most European countries,
and the United States (12,13,28,69–79). The
general time trend in many countries seems
to be toward a slight decrease of dioxin levels
in breast milk over the past decade (3). In
some countries, the decrease has been quite
dramatic, with levels reduced by as much as
50% (69). 
Coordinated WHO studies in Europe
from 1986 to 1993 showed an average
decrease in dioxin levels of approximately
35%, with consistently higher levels in
industrial areas (70) (Table 1). Extensive
data from Sweden (Figure 8) shows a down-
ward trend in average breast milk levels over
25 years, with a relatively steep decline from
the 1970s to the mid-1980s and evidence of
a plateau since the mid-1980s(28,74). In
many other countries, it has been difﬁcult to
make a national assessment of whether levels
are going down because of regional varia-
tions. For instance, in Croatia, average breast
milk levels of dioxin in Krk decreased
between 1986 and 1988, while in Zagreb,
they increased (12,14). Similarly, ﬁndings in
Finland and Kazakhstan showed different
trends for different regions (12,14,79–81). It
is clear that regional variation is important,
and different exposure scenarios may have
resulted in extremely different levels.
More subtle regional variations have been
identified in some studies. For example, in
Finland, significant differences in the con-
gener composition of dioxins in breast milk
emerged in different regions of the country.
The researchers eventually traced the differ-
ences to the types of ﬁsh consumed in these
regions (82). Different species of fish were
contaminated with different congener combi-
nations. Similarly, the specific dioxin con-
geners associated with Agent Orange have
been identified in some subpopulations. In
Vietnam, concentrations of certain dioxin
congeners in breast milk were especially high
after intensive aerial spraying of Agent
Orange during the Vietnam War (83).
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Figure 5. HCB in breast milk in Sweden. Figure 6.β-HCH in breast milk in Stockholm, Sweden.
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Figure 7. β-HCH in breast milk in Japan.
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1976 1978 1980 1982Especially high levels of dioxin in breast milk
as a result of Agent Orange exposure have
also been an issue in Kazakhstan (80). In
Kazakhstan, women in one geographic region
have some of the highest levels in the world
of 2,3,7,8-TCDD in their breast milk: Levels
in primiparous women in the most exposed
area average 53.4 pg/g fat, 10 times higher
than U.S. levels. The levels are most likely
related to the use of Agent Orange to control
weeds in the rice ﬁelds. The dioxin contami-
nants ran off into the lake and accumulated
in ﬁsh, the dietary staple in the region.
Polychlorinated biphenyls. PCBs generally
occur as a mixture of several of 209 individual
congeners. These persistent chemicals were
widely used as flame retardants, in surface
coatings, and in electrical equipment such as
transformers. The most serious effects of
PCBs are on the brain. Low-level PCB expo-
sures, particularly before birth, have been
linked to lower IQ, hyperactivity, shortened
attention span, and delayed acquisition of
reading skills (84,85). PCBs interfere with
thyroid hormone, and some researchers
believe that this mechanism may explain
some of the neurologic effects of PCBs (86).
Thyroid hormone is essential for normal
growth and development of the brain before
birth and throughout infancy (87).
PCBs occur as environmental contami-
nants around the world. Researchers report
that almost all samples of human blood, fat,
or breast milk show some detectable level of
PCBs (88). Many studies evaluating PCB
levels in women have found concentrations
in breast milk that are 4–10 times higher
than in blood. However, some studies indi-
cate that prenatal exposure (via transplacental
transfer) of PCBs that may be more signiﬁ-
cant to the later health of the child (11,89). 
PCBs have been measured in breast milk
of women from at least 35 countries, includ-
ing most of Europe, Greenland, Lithuania,
Nigeria, the United States, and Zaire
(25,28,65,66,69). Because of the challenges
presented by the data measuring PCBs in
breast milk, it is difficult to assess trends.
Some researchers have speculated that, over
the last 25 years, levels may have decreased
slightly (88). However, that conclusion is
hardly deﬁnitive, and the question will most
likely remain unanswered until data standard-
ization issues are addressed. In Sweden, where
data have been collected following fairly 
consistent methods over time, evidence of a
downward trend has emerged (Figure 9) (28). 
Many researchers have investigated the
role of diet in the level of PCBs present in
breast milk. In the United States, fish con-
sumption in the Great Lakes area has been
associated with a higher body burden of PCBs
(90). In Canada, Inuit and fishing popula-
tions have higher levels of PCBs in breast
milk than do urban populations. Figure 10
shows the difference in some PCB congeners
in breast milk levels of Inuit and Caucasian
women in Quebec, Canada, in 1989 and
1990 (69). Inuit women, whose diet includes
ﬁsh and marine mammals, had much higher
breast milk levels than urban, Caucasian
women. Fish and marine mammal consump-
tion are not the only dietary exposures of con-
cern. In the Czech Republic, the use of a
PCB-containing paint in grain silos led to
breast milk levels higher than those found in
neighboring regions and countries (65). 
Polybrominated diphenyl ethers. PBDEs
are a class of widely used flame retardants.
They are added to the plastic material in tele-
visions and computers and are also found in
construction materials, furniture, and textiles
(7). Unlike the PCBs and many of the
organochlorine pesticides, the PBDEs are still
widely used throughout the world. The pro-
duction and use of PBDEs have steadily
increased since the 1970s. PBDEs can enter
the environment during the production and
disposal of materials containing PBDE ﬂame
retardants, as well as during the lifetime of
PBDE-containing products. PBDEs are not
chemically bound to plastics, so they can evap-
orate into indoor air or the outdoor environ-
ment (91). Once released, PBDEs can build
up in the environment and in living organ-
isms, binding strongly to sediment and build-
ing up in ﬁsh and other aquatic organisms (7). 
The similarity of the PBDEs to dioxins
and PCBs has been a concern because their
negative effects on health may prove to be
similar (92). In particular, scientists have
found indications that the PBDEs may affect
hormone function and may be toxic to the
developing brain (93). The PBDEs have
been associated with non-Hodgkin lym-
phoma in humans, a variety of cancers in
rodents, and disruptions of thyroid hormone
balance (92). No restrictions have been
placed on the production and use of PBDEs,
but the Swedish government has announced
an intention to ban PBDEs in products sold
in Sweden, based partly on the detection of
these chemicals in breast milk (28,92). 
Only a few studies have sought to mea-
sure PBDEs in breast milk. Extensive data
from Sweden and some limited data from
Germany have been collected. In the
Swedish study, archived samples collected
between 1972 and 1997 were analyzed for
the presence of PBDEs to get an overall
summed total of PBDEs in milk (7,28). An
average for each time period was calculated
(Figure 11). The data from Sweden show a
logarithmic increase in the quantity of
PBDEs detected in women’s breast milk. 
Toxic metals. A number of potentially
toxic metals have been reported in breast
milk, including lead, mercury, cadmium,
and arsenic. Unlike the POPs, metals do not
bind to fat and so do not usually accumulate
to higher concentrations in breast milk than
in blood (94). As a result, infants are likely
to be exposed to higher levels before birth
than during breast-feeding. Nonetheless,
metals in breast milk are important as an
additional pathway of exposure and as an
indicator of likely prenatal exposures. 
Metals have been detected in breast milk
around the world. Twenty-six countries have
conducted studies detecting toxic metals,
including Bulgaria, Guatemala, Hungary,
Iraq, Malaysia, the Philippines, Rumania, and
the United States. A WHO study on trace
elements in breast milk showed that levels of
mercury are extremely variable around the
world. Among women who eat a lot of ﬁsh,
for example, levels of mercury in breast milk
may exceed levels in unexposed women by
100-fold (95). Peak measured levels of lead
and cadmium worldwide exceed the median
by 10-fold, whereas the measured range for
arsenic levels is low and very narrow (22).
Several studies have found higher blood
lead levels in formula-fed infants than in
breast-fed infants (96). This may be a result of
contaminated formula cans or formula pre-
pared using tap water with high lead levels.
Lead levels in blood and breast milk correlate
closely with areas where lead is still used in
gasoline, with the highest levels in areas with
heavy trafﬁc. In addition, mothers in coun-
tries where lead is still used in gasoline, and
mothers living near lead smelters have higher
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Figure 9. PCBs in breast milk in Sweden.
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Figure 8. Dioxins in breast milk in Sweden.
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Table 1. Dioxins in breast milk in the European
Union.
1988 1993 Change
Rural 28.2 17.7 37% decrease
Urban 29.5 19.2 35% decrease
Industrial 35.9 24 33% decrease
Data shown are average concentrations (pg I-TEQ/g fat).levels of lead in their breast milk due to com-
munity contamination (Figure 12) (97).
Much of the lead in breast milk does not
come from the mothers’ exposures during lac-
tation. Instead, it comes from lead stored in
the bones. Calcium extraction from bone is
greatest during lactation, and, as a result, lead
stored in the mother’s bones also enters the
blood and breast milk during pregnancy and
lactation, posing an exposure risk to the fetus
(98). Fortunately, sufficient calcium intake
during pregnancy and lactation reduces the
extraction of lead from bone (99). Thus
women can signiﬁcantly reduce their child’s
exposure to lead by getting adequate calcium
during pregnancy and lactation.
Breast milk levels of mercury are usually
lower than levels of lead. Mercury does not
accumulate in breast milk; in fact, the levels
in the mother’s blood are generally about
three times higher than the levels in milk
(97). Therefore, prenatal exposure is gener-
ally more important than lactational expo-
sure to mercury. Two major forms of
mercury can enter breast milk. The most haz-
ardous, methylmercury, does not enter breast
milk at high rates because it is attached to red
blood cells. But what little does get into
breast milk is easily absorbed in the intestine
of a nursing infant. The second form, inor-
ganic mercury, enters breast milk easily but is
not well absorbed in the infant’s gastroin-
testinal system (100). 
In the past, mercury has been responsible
for mass poisonings in Minamata, Japan,
and in Iraq. In both cases, food contami-
nated with methylmercury led to illness and
death. Some of those affected were breast-
feeding children whose mothers had eaten
the contaminated food. However, in both of
these scenarios, the levels of mercury were
far higher than those reported in ﬁsh-eating
populations today (95).
Cadmium levels in breast milk are signif-
icantly associated with cigarette smoking.
One German study showed a direct relation-
ship between the number of cigarettes a
mother smokes per day and the level of cad-
mium in her breast milk (101). However,
some studies indicate that an infant’s expo-
sure to cadmium from soy infant formula is
about 20 times higher than the levels gener-
ally found in breast milk (102).
Solvents. Organic solvents are ubiquitous
in both industrial and household settings.
These chemicals are present in paints, var-
nishes, thinners, dry-cleaning fluids, some
glues, degreasers, and gasoline. Solvents
include a wide variety of chemicals with
varying properties, deﬁned more by their use
than by their chemistry or toxicity. In gen-
eral, organic solvents are highly volatile and
readily absorbed through the skin. These
chemicals are also common water contami-
nants. As a result of their widespread pres-
ence in the environment, solvents are found
in human urine, exhaled breath, blood, and
fat (103). Because solvents are relatively
short-lived in the body, detection implies
recent exposure. 
Numerous organic solvents have been
detected in breast milk, including benzene,
chloroform, methylene chloride, styrene, per-
chloroethylene, toluene, trichloroethylene,
1,1,1-trichloroethane, and xylene (104).
Breast milk levels of these compounds may be
higher than blood levels in part because breast
tissue does not eliminate solvents as quickly as
does blood (104). Perchloroethylene, in par-
ticular, is known to concentrate in breast milk
to levels about three times higher than levels
in blood (105). That said, much of the
research on this group of chemicals has been
preliminary and is of two types: theoretical
models estimating which solvents may get
into breast milk, and small monitoring stud-
ies (106). The short-lived nature of solvents
makes sampling difficult because samples
need to be collected and transported in a
specialized way and analyzed quickly so they
do not evaporate away between the time of
collection and the time of analysis. Most
countries have not conducted studies of sol-
vents in breast milk and have gathered no
data representative of the general population.
Due to limited data, it is possible only to
conclude that some solvents get into breast
milk; no information relevant to the levels of
exposure, geographic differences, or time
trends are available.
In one case report, a lactating mother who
visited her husband daily at a dry cleaning
ﬁrm had high levels of perchloroethylene in
her milk (107). This case does not reﬂect nor-
mal population-level exposure to per-
chloroethylene; however, it is an important
indicator of the potential for exposure to the
nursing infant. A modeling study predicted
elevated levels of perchloroethylene in the
breast milk of women living in apartments in
buildings containing dry cleaning businesses
(108). In another modeling study, three sol-
vents (perchloroethylene, bromochloroethane,
and 1,4-dioxane) were estimated to accumu-
late in breast milk in excess of the U.S.
Environmental Protection Agency’s (EPA)
health advisory level for drinking water if the
mother was exposed at the legally allowable
workplace limit (105). In addition, predicted
breast milk levels of carbon tetrachloride and
trichloroethylene were extremely close to the
U.S. EPA health advisory level. These esti-
mates are likely to underestimate potential
risk to breast-feeding children of mothers
exposed to solvents in the workplace because
the U.S. EPA risk values used were for non-
cancer health effects in adults, whereas several
of the solvents evaluated are carcinogens and
the exposure is to neonates. 
Solvents are an avoidable source of
potential chemical exposures. Although little
information has been gathered about these
chemicals in breast milk, we do know that
many solvents can enter the mother’s body
and then transfer into her milk. Because use
of these chemicals is so widespread, the sub-
ject merits further research.
Summary
Although monitoring of environmental
xenobiotics in breast milk has been relatively
limited, the available data do provide some
useful information about patterns of pollu-
tion over time and determinants of exposure.
Many of the persistent organic pollutants
have signiﬁcantly decreased in countries that
have placed bans on production and use.
Exposure varies significantly based on local
chemical use and on dietary habits in the
population under study. International efforts
to eliminate persistent organic pollutants
may help address some of the areas where
levels remain high. 
Breast milk contamination is an impor-
tant indicator of potential future public health
and environmental problems. Increasing lev-
els of the brominated diphenyl ethers and
recent reported detections of other chemicals
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Figure 10. Speciﬁc PCB congeners in breast milk in
Canada (1989–1990). Data from Dewailly et al. (69).
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Figure 11. PBDEs in breast milk in Sweden. 
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Figure 12. Lead in breast milk by location.
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Malaysiasuch as naphthalenes and various cosmetic
products including musk xylenes, nitro musks,
polycyclic musks, octyl methoxycinnamate,
and benzophenone-3 (74,109–111) create a
compelling reason to research the health
effects of these chemicals, increase monitoring
efforts, and design health-based strategies for
reducing or eliminating exposure.
It is critical to move beyond studies of the
same small group of chemicals in a few sub-
jects in limited geographic areas using incon-
sistent protocols to a more systematic
international breast milk monitoring program
(3,112). Such a program would use a consis-
tent protocol to monitor for an expanded
range of suspected contaminants. The results
would be useful to guide research and public
health interventions worldwide. It is only
with more information from many women
and in many locations that we will be able to
track trends, identify potential hazards, and
protect future generations.
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